Skip to main content

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials.

Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider 'research-based' reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research.

Debates will also be encouraged in the correspondence section of this journal.

Publisher: Bentham Science Publishers

Volume 10, Number 4, July 2012

Articles

HDL-Related Mechanisms of Olive Oil Protection in Cardiovascular Disease
pp. 392-409(18)
Authors: M. Lou-Bonafonte, Jose; Fito, Montse; Covas, Maria-Isabel; Farras, Marta; Osada, Jesus

Favourites:
ADD

Proteomics Investigations of HDL: Challenges and Promise
pp. 410-421(12)
Author: Vaisar, Tomas

Favourites:
ADD

Lipid and Apoprotein Composition of HDL in Partial or Complete CETP Deficiency
pp. 422-431(10)
Authors: J. Niesor, Eric; von der Mark, Elisabeth; Calabresi, Laura; Averna, Maurizio; B. Cefalu, Angelo; Tarugi, Patrizia; Nilsson, Peter; Dernick, Gregor

Favourites:
ADD

Omega-3 Fatty Acids and HDL. How Do They Work in the Prevention of Cardiovascular Disease?
pp. 432-441(10)
Authors: Burillo, Elena; Martin-Fuentes, Paula; Mateo-Gallego, Rocio; Baila-Rueda, Lucia; Cenarro, Ana; Ros, Emilio; Civeira, Fernando

Favourites:
ADD

GP IIb/IIIa Inhibitors for STEMI: Still the Gold Standard or an Old Survivor?
pp. 443-447(5)
Authors: Musumeci, Giuseppe; Baroni, Matteo; Rossini, Roberta

Favourites:
ADD

Intracoronary Use of GP IIb/IIIa Inhibitors in Percutaneous Coronary Interventions
pp. 448-453(6)
Authors: De Vita, Maria; Coluccia, Valentina; Burzotta, Francesco; Romagnoli, Enrico; Trani, Carlo

Favourites:
ADD

Prasugrel During Primary Percutaneous Coronary Intervention: Evidence from Clinical Data
pp. 454-457(4)
Authors: Biondi-Zoccai, Giuseppe; Abbate, Antonio; D'Ascenzo, Fabrizio; Lotrionte, Marzia; G. Modena, Maria

Favourites:
ADD

Ticagrelor in ST-Elevation Myocardial Infarction
pp. 458-462(5)
Authors: A. Sgueglia, Gregory; Tarantini, Giuseppe; Niccoli, Giampaolo

Favourites:
ADD

Prevention and Treatment of Coronary Distal Embolization in the Setting of Acute Myocardial Infarction: Pharmacologic Approach
pp. 463-467(5)
Authors: R. De Caterina, Alberto; Porto, Italo; Luigi De Maria, Giovanni; P. Banning, Adrian

Favourites:
ADD

Cilostazol and Primary-PCI: Mirage or Good Alternative?
pp. 468-471(4)
Authors: Porto, Italo; D'Amario, Domenico; Crea, Filippo

Favourites:
ADD

Drug Coated Balloons in Acute Coronary Syndromes - Opportunities and Limitations
pp. 472-475(4)
Authors: Scheller, Bruno; Clever, Yvonne; Bohm, Michael; Cremers, Bodo

Favourites:
ADD

In the Bivalirudin Era, Are We Still Looking for a Potent Antiplatelet Agent?
pp. 476-478(3)
Authors: Cortese, Bernardo; Pitì, Antonino; Kastrati, Adnan; Sibbing, Dirk

Favourites:
ADD

Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies
pp. 479-493(15)
Authors: Ferroni, Patrizia; Della-Morte, David; Palmirotta, Raffaele; Rundek, Tatjana; Guadagni, Fiorella; Roselli, Mario

Favourites:
ADD

Antiplatelet Therapy in Patients with Diabetes Mellitus
pp. 494-505(12)
Authors: L. Grove, Erik; Gregersen, Soren

Favourites:
ADD

Blood Pressure Control and Antihypertensive Treatment
pp. 506-511(6)
Authors: Grassi, Guido; Seravalle, Gino; Quarti Trevano, Fosca; Dell'Oro, Raffaella; Mancia, Giuseppe

Favourites:
ADD

Cytochrome P450 1B1 and 2C9 Genotypes and Risk of Ischemic Vascular Disease, Cancer, and Chronic Obstructive Pulmonary Disease
pp. 512-520(9)
Authors: Kaur-Knudsen, Diljit; E. Bojesen, Stig; G. Nordestgaard, Borge

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more